Progesterone

Progesterone, also known as P4, is a sex hormone. As a biomarker, it indicates the concentration of progesterone measured in the body, providing a quantitative view of this hormone at the time of measurement.

Progesterone is tested using a serum sample, meaning the measurement is taken from blood after the serum has been separated. Fasting is not required for this test, so the sample can be arranged without fasting-related preparation.

When reviewing the result, use the reference interval that corresponds to the person’s sex, since the listed ranges differ. The optimal range is narrower than the broader reference range, so a result may be within the general reference interval without being within the optimal interval. Results are reported in ng/mL.

Progesterone may also be considered alongside Estradiol, Lh, and Fsh. These related markers can provide additional context when interpreting the result, rather than relying on progesterone alone. A clinician can help determine which comparison range and accompanying markers are appropriate for the individual’s circumstances.

Progesterone is measured in serum and reported in ng/mL. The reference range is the broader interval used to identify results that fall within the laboratory’s stated range, while the optimal range is a narrower interval within it. These ranges serve different purposes, so a result may be inside the reference range without being inside the tighter optimal range.

Interpret the number against the range and units printed on the report. Laboratories may use different ranges or units, and sex-specific ranges may also apply, so the same number should not be interpreted in isolation. Fasting is not required for this measurement.

A single progesterone value is not a diagnosis. Results outside the reported range, or results that raise concern in context, should be discussed with a clinician who can interpret them alongside the reason for testing and other relevant clinical information.

Progesterone was measured directly in trials of both L-Carnitine and Ashwagandha, and both interventions were associated with increases. Because the marker itself was measured, these findings are more direct than evidence based only on related outcomes.

The L-Carnitine evidence came from a meta-analysis, while the Ashwagandha evidence came from a randomized controlled trial. The Ashwagandha trial reassessed progesterone after 8 weeks. These results describe movement in progesterone, not whether a particular value is optimal for every person; interpretation depends on the relevant reference range and clinical context.

The findings do not establish that either intervention will produce the same change for everyone, and they do not by themselves indicate how progesterone should be managed for a medical condition. A clinician can help interpret progesterone results alongside symptoms, timing, and other relevant factors.